Pay in 4 interest-free payments of $6.79 Learn more
Ships within 48 hours · Estimated delivery Jul 31 - Aug 5
Stimulates dermal papilla activity and hair follicle regeneration in individuals with thinning hair or androgenic alopecia
Sources Phase 2 Retatrutide Trial (NEJM) Triple hormone receptor agonist retatrutide for metabolic dysfunctionassociated steatotic liver disease Triple Agonism Review (PMC) Triple Agonism Based Therapies for Obesity Retatrutide Game Changer Review RetatrutideA Game Changer in Obesity Pharmacotherapy The Atlantic GLP3 Underground Market GoodRx Retatrutide Availability & Dosage Retatrutide for Weight Loss: Availability, Dosage, and More Phase 3 Trial Update (Clinical Trials Arena) Lillys triple G agonist boasts 28.7% weight loss in Phase III trial Retatrutide FDA Status 2026 Retatrutide FDA Approval Status 2026: Phase 3 Results Update GLP3 Retatrutide FAQ (Expert) GLP3 Retatrutide Peptide Expert FAQ Dr
Wichtig: Dies ist keine Genehmigung, sondern eine Regulierungslcke
PCPs Cautious with GLP-1 Prescriptions Despite increasing patient demand, PCPs remain generally cautious when prescribing GLP-1 medications
US$ 23.26
US$ 27.08
US$ 23.75
US$ 23.01
US$ 28.32
